Deferiprone for the treatment of transfusional iron overload in thalassemia-Reference-Cited by-同舟云学术

Deferiprone for the treatment of transfusional iron overload in thalassemia

Published:2017-06-02 Issue:6 Volume:10 Page:493-503
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Belmont Ami¹,Kwiatkowski Janet L.²

Affiliation:

1. Alpert Medical School of Brown University, Providence, RI, USA

2. Children’s Hospital of Philadelphia, Division of Hematology and Perelman School of Medicine at the University of Pennsylvania, Department of Pediatrics, Philadelphia, PA, USA

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2017.1318052

Reference85 articles.

1. Effect of transfusional iron intake on response to chelation therapy in β-thalassemia major

2. Pathophysiology and Clinical Manifestations of the -Thalassemias

3. Iron Loading and Overloading due to Ineffective Erythropoiesis

4. High nontransferrin bound iron levels and heart disease in thalassemia major

5. SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron overload: The achilles heel of β-thalassemia;Transfusion Clinique et Biologique;2024-08

2. Mitochondrial ferritin upregulation reduced oxidative stress and blood-brain-barrier disruption by maintaining cellular iron homeostasis in a neonatal rat model of germinal matrix hemorrhage;Experimental Neurology;2024-04

3. Real‐world evidence: Long‐term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years;American Journal of Hematology;2024-03

4. Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature;American Journal of Cardiovascular Drugs;2023-12-29

5. The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group;Acta Haematologica;2023-12-16